Bellicum Pharmaceuticals, Inc. (BLCM) Stock Increasing in Aftermarket Despite Clear Reason.
Bellicum Pharmaceuticals, Inc. (BLCM) is a leading innovative clinical stage pharmaceutical company focusing on the treatment of hematological cancers and solid tumors using cellular immunotherapy.